Lv6
1640 积分 2024-12-03 加入
Dual inhibition of BRAF for cancer treatment: advances and therapeutic potential
1天前
已完结
The past, present, and future of ALK-targeted drug discovery
11天前
已完结
ALK in cancer: from function to therapeutic targeting
13天前
已完结
Elucidating CTLA-4’s role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments
1个月前
已完结
Cellular and pathological functions of tau
1个月前
已完结
IL-33 in cancer immunotherapy: pleiotropic functions and biological strategies
2个月前
已完结
Selective inhibition of Tumor necrosis factor receptor-1 (TNFR1) for the treatment of autoimmune diseases
2个月前
已完结
TNFR2 signalling in inflammatory diseases
3个月前
已完结
Targeting glypican 3 by Immunotoxins; the promise of immunotherapy in hepatocellular carcinoma
3个月前
已完结
Nectin-4: A promising prognostic marker and therapeutic target in cancer
3个月前
已完结
皖公网安备34019202002308
